| Restorative retinal laser therapy: Present state and future directions J Chhablani, YJ Roh, AI Jobling, EL Fletcher, JJ Lek, P Bansal, R Guymer, ... Survey of ophthalmology 63 (3), 307-328, 2018 | 70 | 2018 |
| New diagnostic and therapeutic approaches for preventing the progression of diabetic retinopathy YG Park, YJ Roh Journal of diabetes research 2016 (1), 1753584, 2016 | 60 | 2016 |
| Diabetic retinopathy is associated with subclinical atherosclerosis in newly diagnosed type 2 diabetes mellitus JW Son, EH Jang, MK Kim, IT Kim, YJ Roh, KH Baek, KH Song, KH Yoon, ... Diabetes research and clinical practice 91 (2), 253-259, 2011 | 57 | 2011 |
| Laser‐based strategies to treat diabetic macular edema: history and new promising therapies YG Park, EY Kim, YJ Roh Journal of Ophthalmology 2014 (1), 769213, 2014 | 54 | 2014 |
| One-year results of intravitreal ranibizumab for neovascular age-related macular degeneration and clinical responses of various subgroups S Kang, YJ Roh Japanese journal of ophthalmology 53, 389-395, 2009 | 47 | 2009 |
| Safety and efficacy of selective retina therapy (SRT) for the treatment of diabetic macular edema in Korean patients YG Park, JR Kim, S Kang, E Seifert, D Theisen-Kunde, R Brinkmann, ... Graefe's Archive for Clinical and Experimental Ophthalmology 254, 1703-1713, 2016 | 46 | 2016 |
| Selective retina therapy in patients with chronic central serous chorioretinopathy: a pilot study S Kang, YG Park, JR Kim, E Seifert, D Theisen-Kunde, R Brinkmann, ... Medicine 95 (3), e2524, 2016 | 45 | 2016 |
| Glutathione depletion induces differential apoptosis in cells of mouse retina, in vivo YJ Roh, C Moon, SY Kim, MH Park, YC Bae, MH Chun, JI Moon Neuroscience letters 417 (3), 266-270, 2007 | 39 | 2007 |
| Risk factors for the development and progression of diabetic kidney disease in patients with type 2 diabetes mellitus and advanced diabetic retinopathy KJ Yun, HJ Kim, MK Kim, HS Kwon, KH Baek, YJ Roh, KH Song Diabetes & metabolism journal 40 (6), 473, 2016 | 38 | 2016 |
| The antiangiogenic effects of gold nanoparticles on experimental choroidal neovascularization in mice YJ Roh, CR Rho, WK Cho, S Kang Investigative ophthalmology & visual science 57 (15), 6561-6567, 2016 | 37 | 2016 |
| Tissue response of selective retina therapy by means of a feedback‐controlled energy ramping mode YG Park, E Seifert, YJ Roh, D Theisen‐Kunde, S Kang, R Brinkmann Clinical & experimental ophthalmology 42 (9), 846-855, 2014 | 37 | 2014 |
| Selective retina therapy with automatic real-time feedback-controlled dosimetry for chronic central serous chorioretinopathy in Korean patients YG Park, S Kang, M Kim, N Yoo, YJ Roh Graefe's Archive for Clinical and Experimental Ophthalmology 255, 1375-1383, 2017 | 35 | 2017 |
| Antiangiogenic effects of axitinib, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, on laser-induced choroidal neovascularization in mice S Kang, CR Roh, WK Cho, KC Park, KJ Yang, HS Choi, SH Kim, YJ Roh Current eye research 38 (1), 119-127, 2013 | 31 | 2013 |
| One-year results of intravitreal ranibizumab with or without photodynamic therapy for polypoidal choroidal vasculopathy MH Song, HW Ryu, YJ Roh Ophthalmologica 226 (3), 119-126, 2011 | 31 | 2011 |
| Intravitreal ranibizumab in a patient with choroidal neovascularization secondary to choroidal osteoma MH Song, YJ Roh Eye 23 (8), 1745-1746, 2009 | 27 | 2009 |
| Role of intravitreal antivascular endothelial growth factor injections for choroidal neovascularization due to choroidal osteoma AM Mansour, JF Arevalo, E Al Kahtani, H Zegarra, E Abboud, R Anand, ... Journal of Ophthalmology 2014 (1), 210458, 2014 | 25 | 2014 |
| New Approach of Anti‐VEGF Agents for Age‐Related Macular Degeneration YG Park, HW Rhu, S Kang, YJ Roh Journal of Ophthalmology 2012 (1), 637316, 2012 | 21 | 2012 |
| Intravitreal ranibizumab for choroidal neovascularisation in serpiginous choroiditis MH Song, YJ Roh Eye 23 (9), 1873-1875, 2009 | 21 | 2009 |
| Intravitreal ranibizumab for choroidal neovascularisation secondary to angioid streaks S Kang, YJ Roh Eye 23 (8), 1750-1751, 2009 | 20 | 2009 |
| One year results of intravitreal ranibizumab monotherapy for retinal angiomatous proliferation: a comparative analysis based on disease stages YG Park, YJ Roh BMC ophthalmology 15, 1-7, 2015 | 19 | 2015 |
